EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access

Evaluation of Sample Pooling Strategies for Point‐of‐Care HPV DNA Testing Using the STANDARD™ M10 Platform

Ahmad Asyraf Senian iD, Vaenessa Noni iD, Abigail Rembui Jerip, Andy Cheong Shin Bong iD, Dzuriaty Siri-Ee, Cheng Siang Tan iD

Journal of Medical Virology · 2026

DOI: 10.1002/jmv.71101 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Ahmad Asyraf Senian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paraclinical Sciences, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak, Kota Samarahan, Sarawak, Malaysia. Hauptthemen laut MEDLINE: Papillomavirus Infections, Human Papillomavirus Viruses, DNA, Viral, Specimen Handling. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Program SUARA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human papillomavirus (HPV) DNA testing is the recommended primary screening method for cervical cancer prevention. However, implementation in resource‐limited and geographically challenging settings is constrained by cost, logistics, and time‐sensitive screen‐and‐treat workflow. Sample pooling may improve testing efficiency, but evidence for its feasibility on point‐of‐care molecular platforms remains limited. We evaluated the analytical performance and feasibility of sample pooling for high‐risk HPV (hrHPV) detection using the STANDARD™ M10 HPV point‐of‐care assay. Archived self‐collected vaginal swab samples from a rural cervical cancer screening programme, Programme SUARA, in Sarawak, Malaysia, were used, including four hrHPV‐positive samples spanning a range of cycle threshold (Ct) values and seven hrHPV‐negative samples. Pooling strategies of 2‐in‐1, 4‐in‐1, and 8‐in‐1 were assessed using a Dorfman two‐stage testing approach. Qualitative agreement, sensitivity, Ct shifts, and concordance with individual testing were analyzed. All hrHPV‐positive samples were consistently detected across individual and pooled formats, with no false‐negative results observed. Sensitivity remained 100% for all pooling strategies, with perfect agreement between pooled and individual testing ( κ = 1.0). Pooling resulted in modest Ct shifts, with mean increases of +1.0, +1.7, and +1.8 cycles for 2‐in‐1, 4‐in‐1, and 8‐in‐1 pools, respectively, without compromising qualitative detection, including samples with low viral loads. Sample pooling for hrHPV DNA testing using the STANDARD™ M10 platform is analytically reliable and operationally feasible. These findings support pooled testing as an evidence‐based strategy to improve throughput, reduce resource consumption, and enable same‐day screen‐and‐treat workflows in resource‐limited and remote settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsHuman Papillomavirus VirusesDNA, ViralSpecimen HandlingPapillomaviridaePoint-of-Care SystemsHumansFemalePooled TestingSensitivity and SpecificityMalaysiaUterine Cervical NeoplasmsEarly Detection of CancerVaginaRapid Diagnostic Tests

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Department of Paraclinical Sciences, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak, Kota Samarahan, Sarawak, Malaysia.
  • Centre for Tropical and Emerging Diseases, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak, Kota Samarahan, Sarawak, Malaysia.
  • Therapeutic Research Centre, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak, Kota Samarahan, Sarawak, Malaysia.
  • Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak, Kota Samarahan, Sarawak, Malaysia.
  • Pink and Teal Empowher, Kota Padawan, Kuching, Sarawak, Malaysia.

ORCID-Profile: Ahmad Asyraf Senian, Vaenessa Noni, Andy Cheong Shin Bong, Cheng Siang Tan

Förderung

  • Program SUARA

Zitieren

APA

Senian, A. A., Noni, V., Jerip, A. R., Bong, A. C. S., Siri-Ee, D., & Tan, C. S. (2026). Evaluation of Sample Pooling Strategies for Point‐of‐Care HPV DNA Testing Using the STANDARD™ M10 Platform. Journal of Medical Virology. https://doi.org/10.1002/jmv.71101

Vancouver

Senian AA, Noni V, Jerip AR, Bong ACS, Siri-Ee D, Tan CS. Evaluation of Sample Pooling Strategies for Point‐of‐Care HPV DNA Testing Using the STANDARD™ M10 Platform. Journal of Medical Virology. 2026. doi:10.1002/jmv.71101

BibTeX
@article{Senian2026,
  author = {Senian, Ahmad Asyraf and Noni, Vaenessa and Jerip, Abigail Rembui and Bong, Andy Cheong Shin and Siri-Ee, Dzuriaty and Tan, Cheng Siang},
  title = {Evaluation of Sample Pooling Strategies for Point‐of‐Care HPV DNA Testing Using the STANDARD™ M10 Platform},
  journal = {Journal of Medical Virology},
  year = {2026},
  doi = {10.1002/jmv.71101}
}
Kostenlos starten →